Total Payments
$36,249
2021 Payments
$2,428
Companies
1
Transactions
39
Medicare Patients
3,837
Medicare Billing
$537,624
Payment Breakdown by Category
Consulting$36,249 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $36,249 | 39 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $36,249 | 39 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $2,428 | 5 | Merck Sharp & Dohme Corporation ($2,428) |
| 2020 | $1,733 | 6 | Merck Sharp & Dohme Corporation ($1,733) |
| 2019 | $8,333 | 7 | Merck Sharp & Dohme Corporation ($8,333) |
| 2018 | $4,950 | 11 | Merck Sharp & Dohme Corporation ($4,950) |
| 2017 | $18,805 | 10 | Merck Sharp & Dohme Corporation ($18,805) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $1,440.00 | General |
| Category: ONCOLOGY | ||||||
| 07/01/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $202.00 | General |
| Category: ONCOLOGY | ||||||
| 04/28/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $221.00 | General |
| Category: ONCOLOGY | ||||||
| 02/11/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $303.00 | General |
| Category: ONCOLOGY | ||||||
| 02/11/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $262.00 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $221.00 | General |
| Category: ONCOLOGY | ||||||
| 08/26/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $243.00 | General |
| Category: ONCOLOGY | ||||||
| 07/02/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $262.00 | General |
| Category: ONCOLOGY | ||||||
| 06/18/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $202.00 | General |
| Category: ONCOLOGY | ||||||
| 06/04/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $243.00 | General |
| Category: ONCOLOGY | ||||||
| 01/16/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $562.00 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $407.00 | General |
| Category: ONCOLOGY | ||||||
| 11/28/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $726.00 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $3,039.00 | General |
| Category: ONCOLOGY | ||||||
| 04/17/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $3,198.00 | General |
| Category: ONCOLOGY | ||||||
| 04/11/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $420.00 | General |
| Category: ONCOLOGY | ||||||
| 04/11/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $382.00 | General |
| Category: ONCOLOGY | ||||||
| 04/11/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $161.00 | General |
| Category: ONCOLOGY | ||||||
| 08/23/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $60.00 | General |
| Category: ONCOLOGY | ||||||
| 08/09/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $562.00 | General |
| Category: ONCOLOGY | ||||||
| 07/05/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $221.00 | General |
| Category: ONCOLOGY | ||||||
| 05/17/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $1,149.00 | General |
| Category: ONCOLOGY | ||||||
| 05/17/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $420.00 | General |
| Category: ONCOLOGY | ||||||
| 04/19/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $631.00 | General |
| Category: ONCOLOGY | ||||||
| 04/19/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $180.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,067 | 47,032 | $1.6M | $152,183 |
| 2022 | 13 | 804 | 27,467 | $1.1M | $107,620 |
| 2021 | 18 | 987 | 32,574 | $230,671 | $138,640 |
| 2020 | 14 | 979 | 44,642 | $270,943 | $139,180 |
Total Patients
3,837
Total Services
151,715
Medicare Billing
$537,624
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 288 | 291 | $724,226 | $71,914 | 9.9% |
| 74183 | Mri scan of abdomen before and after contrast | Office | 2023 | 90 | 90 | $330,246 | $22,970 | 7.0% |
| 74174 | Ct scan of blood vessels of abdomen and pelvis with contrast | Office | 2023 | 38 | 39 | $144,105 | $12,509 | 8.7% |
| 74230 | Imaging for evaluation of swallowing function | Office | 2023 | 85 | 86 | $42,681 | $8,604 | 20.2% |
| 72197 | Mri scan of pelvis before and after contrast | Office | 2023 | 32 | 34 | $135,658 | $8,354 | 6.2% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 30 | 31 | $48,112 | $4,781 | 9.9% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 252 | 36,964 | $27,152 | $4,322 | 15.9% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 14 | 14 | $41,020 | $3,748 | 9.1% |
| 74221 | Double contrast x-ray of esophagus | Office | 2023 | 32 | 32 | $20,288 | $2,647 | 13.0% |
| 76391 | Mri and low frequency vibrations for measuring tissue stiffness | Office | 2023 | 18 | 18 | $22,662 | $2,538 | 11.2% |
| A9585 | Injection, gadobutrol, 0.1 ml | Office | 2023 | 91 | 9,200 | $13,363 | $2,419 | 18.1% |
| 76377 | 3d radiographic procedure with computerized image postprocessing | Office | 2023 | 39 | 39 | $25,115 | $2,178 | 8.7% |
| A9581 | Injection, gadoxetate disodium, 1 ml | Office | 2023 | 14 | 150 | $7,190 | $1,733 | 24.1% |
| J1611 | Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg | Office | 2023 | 18 | 18 | $7,248 | $1,563 | 21.6% |
| 74183 | Mri scan of abdomen before and after contrast | Facility | 2023 | 12 | 12 | $13,488 | $988.03 | 7.3% |
| 74220 | Single contrast x-ray of esophagus | Office | 2023 | 14 | 14 | $5,446 | $915.64 | 16.8% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2022 | 147 | 147 | $364,755 | $36,234 | 9.9% |
| 74183 | Mri scan of abdomen before and after contrast | Office | 2022 | 87 | 87 | $310,170 | $22,812 | 7.4% |
| 74230 | Imaging for evaluation of swallowing function | Office | 2022 | 130 | 133 | $64,519 | $14,150 | 21.9% |
| 72197 | Mri scan of pelvis before and after contrast | Office | 2022 | 38 | 38 | $147,808 | $9,069 | 6.1% |
| 74174 | Ct scan of blood vessels of abdomen and pelvis with contrast | Office | 2022 | 16 | 16 | $65,680 | $5,249 | 8.0% |
| J1610 | Injection, glucagon hydrochloride, per 1 mg | Office | 2022 | 30 | 30 | $12,904 | $4,019 | 31.1% |
| 74221 | Double contrast x-ray of esophagus | Office | 2022 | 41 | 41 | $20,951 | $3,659 | 17.5% |
| A9585 | Injection, gadobutrol, 0.1 ml | Office | 2022 | 85 | 8,725 | $12,552 | $2,310 | 18.4% |
| 74220 | Single contrast x-ray of esophagus | Office | 2022 | 32 | 32 | $10,637 | $2,207 | 20.7% |
About Dr. Jay Heiken, MD
Dr. Jay Heiken, MD is a Diagnostic Radiology healthcare provider based in Rochester, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942392444.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jay Heiken, MD has received a total of $36,249 in payments from pharmaceutical and medical device companies, with $2,428 received in 2021. These payments were reported across 39 transactions from 1 company. The most common payment nature is "Consulting Fee" ($36,249).
As a Medicare-enrolled provider, Heiken has provided services to 3,837 Medicare beneficiaries, totaling 151,715 services with total Medicare billing of $537,624. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Diagnostic Radiology
- Other Specialties Diagnostic Radiology
- Location Rochester, MN
- Active Since 09/29/2006
- Last Updated 08/14/2020
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1942392444
Products in Payments
- KEYTRUDA (Biological) $36,249
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Rochester
David Kallmes, M.d, M.D
Diagnostic Radiology — Payments: $1.2M
Diagnostic Radiology $1.2M
Derace Schaffer, M.d, M.D
Diagnostic Radiology — Payments: $1.0M
Diagnostic Radiology $1.0M
Dr. Waleed Brinjikji, M.d, M.D
Diagnostic Radiology — Payments: $891,619
Diagnostic Radiology $891,619
Robert Lorenzetti, Md, MD
Diagnostic Radiology — Payments: $400,302
Diagnostic Radiology $400,302
Jonathan Morris, M.d, M.D
Diagnostic Radiology — Payments: $228,977
Diagnostic Radiology $228,977
Dr. Avice O'connell, M.d, M.D
Diagnostic Radiology — Payments: $213,742
Diagnostic Radiology $213,742